Literature DB >> 29505836

microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.

Xiaoqin Du1, Wanhu Fan2, Yunru Chen3.   

Abstract

microRNAs (miRNAs) are reported to play crucial roles in tumorigenesis. Dysregulation of miR-520f has been implicated to be involved in several cancer progressions. However, the biological functions of miR520f in hepatocellular carcinoma (HCC) remain unclear. Thus, the molecular mechanism underlying miR-520f on HCC development was investigated in this study. Here, we found that miR-520f was remarkably down-regulated in human HCC samples and cell lines compared to paired normal tissues and cell lines as detected by qRT-PCR. Furthermore, the deregulated miR-520f was strongly associated with larger tumor size, advanced TNM stage, and metastasis in HCC patients. Functional investigations revealed that overexpression of miR-520f significantly suppressed cell proliferation, invasion and migration, caused cell cycle arrested at G0/G1 phase, and promoted cell apoptosis in HCC cells according to MTT, colony formation, transwell, and flow cytometry assays, respectively, whereas, downregulation of miR-520f exhibited inverse effects. Transmembrane-4 L-Six family member-1 (TM4SF1) was identified as a direct target of miR-520f, and an inverse relationship was found between miR-520f and TM4SF1 mRNA levels in HCC specimens. Rescue experiments suggested that restoration of TM4SF1 partially abolished miR-520f-meidated cell proliferation and invasion inhibition in HCC cells through regulating P13K/AKT and p38 MAPK signaling pathways. In conclusion, these data indicated that miR-520f acted as tumor suppressor in HCC proliferation and invasion by targeting TM4SF1, which might provide potential therapeutic evidence for HCC patients.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Hepatocellular carcinoma; TM4SF1; miR-520f

Mesh:

Substances:

Year:  2018        PMID: 29505836     DOI: 10.1016/j.gene.2018.03.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent.

Authors:  William M MacCuaig; Alexandra Thomas; Juan C Claros-Sorto; Jorge G Gomez-Gutierrez; Adam C Alexander; Elizabeth A Wellberg; William E Grizzle; Lacey R McNally
Journal:  Biotech Histochem       Date:  2022-01-04       Impact factor: 1.834

Review 2.  The Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Xin Xu; Yuquan Tao; Liang Shan; Rui Chen; Hongyuan Jiang; Zijun Qian; Feng Cai; Lifang Ma; Yongchun Yu
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

3.  MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.

Authors:  Young Ran Park; Seung Young Seo; Se Lim Kim; Shi Mao Zhu; Sungkun Chun; Jung-Mi Oh; Min Ro Lee; Seong Hun Kim; In Hee Kim; Seung Ok Lee; Soo Teik Lee; Sang Wook Kim
Journal:  Biosci Rep       Date:  2018-09-19       Impact factor: 3.840

4.  TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth.

Authors:  Megha Singhal; Mahsa Khatibeghdami; Daniel R Principe; Georgina E Mancinelli; Kyle M Schachtschneider; Lawrence B Schook; Paul J Grippo; Sam R Grimaldo
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

5.  MiR-520f acts as a biomarker for the diagnosis of lung cancer.

Authors:  Yingyan Zhou; Shimo Shen
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.